To quantitatively profile the drug sensitivity with a more robust parameter than the IC50 or EC50 values, the drug sensitivity score (DSS) analysis was employed. DSS values are essentially normalized area under the curve (AUC) measures of dose-response inhibition data (Yadav et al., 2014). Drug response data files (in Excel) ready for online analysis were prepared according to the example file obtained from the DSS pipeline website, called Breeze1 (Potdar et al., 2020). Either raw fluorescence intensity measurements or normalized % inhibition data (for BRET assay analysis) were uploaded.
The output file provides several drug sensitivity measures including EC50 and AUC. We plotted the DSS3 value (Yadav et al., 2014), which was calculated as
where DSS2 is given by the equation
and DSS1 is given by the equation
DSS3 was employed to emphasize drugs that obtain their response area over a relatively wide dose window, as compared to drugs that show increased response only at the higher end of the concentration range. After logistic fitting of the dose-response inhibition data, the area under the curve (AUC) was determined as the exact solution. A 10% minimal activity threshold (t) was set. The maximum (Cmax) and minimum (Cmin) concentrations were used for screening of the inhibitors, with Cmax = x2 and x1 concentration with minimal activity t. The parameter a is the value of the top asymptote, which can be different from 100% inhibition as obtained from 100 μM benzethonium chloride treatment.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.